Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in the USA / NCT07908056
Starting soon Observational

Evaluate Precision of the Test for Lactate in Capillary Whole Blood Specimens Using the i-STAT CG4+ Cartridge With the i-STAT 1 Analyzer

NCT07908056 · tracked via the Priya Life Science USA tracker
Sponsor
Abbott Point of Care
Phase
Observational
Started
2026-10-22
Last updated
2026-10-30

Condition(s) studied

Lactate

Investigational drug(s) / intervention(s)

Fingerstick capillary blood draw

Fingerstick capillary blood draw: Fingerstick capillary blood draw

Study summary

Assess precision of the i-STAT lactate test with the i-STAT CG4+ cartridge on the i-STAT 1 analyzer using two (2) separate capillary blood specimens.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: Subject Inclusion Criteria 1. Signed and dated consent form (waiver/alteration of consent, waiver of documentation of consent may be acceptable, per IRB) 2. ≥ 18 years of age Exclusion Criteria: Subject Exclusion Criteria 1\. Previous enrollment in this study

Primary outcome measure(s)

  • Precision across the reportable range for lactate — Through study completion, an average of 1 year
    The primary outcome measure is to assess the precision across the lactate reportable range for the i-STAT lactate test using the i-STAT CG4+ cartridge on the i-STAT 1 analyzer.

Trial sites (3)

FacilityCityRegionStatus
Hackensack University Medical Center Hackensack New Jersey
Penn State Health Milton S. Hershey Medical Center (Hershey) Hershey Pennsylvania
Medical College of Wisconsin Milwaukee Wisconsin
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07908056 on ClinicalTrials.gov ↗ ← All trials in the USA